160 companies

Decibel Cannabis

Market Cap: CA$57.7m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

DB

CA$0.095

7D

5.6%

1Y

58.3%

Medexus Pharmaceuticals

Market Cap: CA$90.6m

Operates as a pharmaceutical company in Canada and the United States.

MDP

CA$2.74

7D

-6.8%

1Y

24.0%

Aurora Cannabis

Market Cap: CA$349.9m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

ACB

CA$6.43

7D

2.6%

1Y

-25.1%

BioSyent

Market Cap: CA$128.9m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

RX

CA$11.40

7D

-2.1%

1Y

12.4%

1CM

Market Cap: CA$28.8m

Operates as a multi-jurisdictional cannabis company in Canada.

EPIC

CA$0.24

7D

0%

1Y

-41.7%

Innovotech

Market Cap: CA$13.2m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

IOT

CA$0.28

7D

-6.7%

1Y

n/a

Oncolytics Biotech

Market Cap: CA$167.1m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.

ONC

CA$1.65

7D

1.9%

1Y

16.2%

Captor Capital

Market Cap: CA$1.7m

Engages in the retail sale of cannabis products in the United States.

CPTR

CA$0.49

7D

-2.0%

1Y

96.0%

XORTX Therapeutics

Market Cap: CA$4.8m

A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.

XRTX

CA$1.34

7D

3.1%

1Y

-44.2%

Algernon Pharmaceuticals

Market Cap: CA$2.4m

Operates as a clinical stage pharmaceutical development company in Canada and Australia.

AGN

CA$0.065

7D

0%

1Y

-43.5%

Organigram Global

Market Cap: CA$269.1m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

OGI

CA$1.99

7D

-1.5%

1Y

-18.8%

Covalon Technologies

Market Cap: CA$71.0m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.

COV

CA$2.56

7D

-6.9%

1Y

23.1%

Knight Therapeutics

Market Cap: CA$602.7m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

GUD

CA$6.00

7D

-1.5%

1Y

5.3%

Microbix Biosystems

Market Cap: CA$40.8m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

MBX

CA$0.29

7D

0%

1Y

-10.6%

High Tide

Market Cap: CA$273.9m

Engages in the cannabis retail business in Canada.

HITI

CA$3.29

7D

0.3%

1Y

24.6%

Sweet Earth Holdings

Market Cap: CA$6.6m

Does not have significant operations.

SE

CA$0.51

7D

0%

1Y

70.0%

Cronos Group

Market Cap: CA$1.1b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

CRON

CA$2.84

7D

0.7%

1Y

-16.5%

Rakovina Therapeutics

Market Cap: CA$14.4m

A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.

RKV

CA$0.68

7D

-2.9%

1Y

-32.0%

Green Thumb Industries

Market Cap: CA$1.8b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

GTII

CA$8.10

7D

-8.1%

1Y

-49.3%

NanoSphere Health Sciences

Market Cap: CA$359.6k

A nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada.

NSHS

CA$0.035

7D

0%

1Y

-30.0%

Simply Solventless Concentrates

Market Cap: CA$36.9m

Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.

HASH

CA$0.31

7D

29.2%

1Y

-10.1%

Satellos Bioscience

Market Cap: CA$104.0m

A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.

MSCL

CA$0.58

7D

-1.7%

1Y

16.0%

Cardiol Therapeutics

Market Cap: CA$133.1m

A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

CRDL

CA$1.67

7D

-7.7%

1Y

-45.1%

Bright Minds Biosciences

Market Cap: CA$243.7m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

DRUG

CA$36.52

7D

4.5%

1Y

2,490.1%

Planet 13 Holdings

Market Cap: CA$81.3m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

PLTH

CA$0.28

7D

1.9%

1Y

-60.1%

SOL Global Investments

Market Cap: CA$14.2m

A private equity firm specializing in growth capital to small and mid-sized businesses.

SOL

CA$0.085

7D

-10.5%

1Y

30.8%

Medicure

Market Cap: CA$11.6m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

MPH

CA$1.20

7D

0%

1Y

20.0%

Curaleaf Holdings

Market Cap: CA$1.0b

Produces and distributes cannabis products in the United States and internationally.

CURA

CA$1.68

7D

10.5%

1Y

-71.4%

Cipher Pharmaceuticals

Market Cap: CA$313.1m

Operates as a specialty pharmaceutical company in Canada.

CPH

CA$12.42

7D

-3.3%

1Y

38.5%

Medicenna Therapeutics

Market Cap: CA$70.0m

A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.

MDNA

CA$0.80

7D

-3.6%

1Y

-59.0%

Rubicon Organics

Market Cap: CA$29.6m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

ROMJ

CA$0.44

7D

-8.3%

1Y

-8.3%

BriaCell Therapeutics

Market Cap: CA$7.4m

A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.

BCT

CA$1.10

7D

-60.3%

1Y

-92.1%

Nextleaf Solutions

Market Cap: CA$10.9m

A cannabis extraction technology company, engages in the manufacture and distribution of cannabinoid vapes, oils, and softgels in Canada.

OILS

CA$0.06

7D

0%

1Y

-29.4%

RAMM Pharma

Market Cap: CA$1.2m

Engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland.

RAMM

CA$0.01

7D

0%

1Y

-50.0%

iAnthus Capital Holdings

Market Cap: CA$33.7m

Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.

IAN

CA$0.005

7D

0%

1Y

-75.0%

Vaxil Bio

Market Cap: CA$547.9k

A biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer.

VXL

CA$0.21

7D

5.0%

1Y

n/a

Page 1 of 5